F19.17
Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance use disorder, mild, with other (or unknown) substance-induced major neurocognitive disorder
Medical Intelligence & Overview
ICD-10 code F19.17 pertains to a specific mental health condition characterized by the ongoing use of psychoactive substances leading to persistent dementia. This condition falls under the broader category of substance use disorders complicated by neurocognitive impairments. It highlights the serious consequences of prolonged substance abuse, especially when it results in lasting cognitive decline.
Causes & Symptoms
Clinical Causes: Chronic use of various psychoactive substances, such as stimulants, depressants, hallucinogens, or other drugs Prolonged exposure and dependence on these substances Pre-existing mental health conditions that may predispose individuals to substance misuse Environmental and social factors influencing substance use behaviors In some cases, unknown or unspecified substances involved, making exact causes harder to pinpoint
Key Symptoms: Memory difficulties and forgetfulness Reduced cognitive abilities, such as problem-solving and reasoning Confusion or disorientation Problems with attention and concentration Changes in personality or behavior Impaired daily functioning and independence Possible mood disturbances, such as depression or anxiety
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a comprehensive assessment that includes medical history, substance use history, and mental health evaluation. Healthcare providers may use cognitive tests and neuroimaging to assess the extent of neurocognitive decline. The diagnosis is primarily clinical, based on observing persistent cognitive impairments in individuals with a history of psychoactive substance use, with exclusion of other causes of dementia.
Treatment Protocols: Ceasing or reducing the use of psychoactive substances under medical supervision Cognitive rehabilitation therapies to improve or maintain cognitive functioning Psychotherapy, including counseling or behavioral therapies, to address underlying substance use issues Medication management for co-existing mental health conditions Supportive care and social services to assist with daily living and safety Monitoring for progression of cognitive impairment and adjusting treatments as necessary
Clinical Advice & FAQs
Billing Guidance
Is F19.17 a billable ICD-10 code?
Yes, F19.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.17?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced persisting dementia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference